Dr Reddys Laboratories experienced high volume trading during today's session, with the stock declining by 1.97% to a price of Rs 1160.00. The movement has drawn attention, especially given the stock's significance as part of the NIFTY 50 index. The high trading volume suggests increased investor activity in Dr Reddys Laboratories.
A review of Dr Reddys Laboratories' recent financial performance provides additional context.
Quarterly Highlights:| Quarter | Revenue (Cr) | Net Profit (Cr) | EPS |
|---|---|---|---|
| Dec 2023 | 7,236.80 | 1,378.20 | 82.94 |
| Mar 2024 | 7,113.80 | 1,306.30 | 78.66 |
| Jun 2024 | 7,696.10 | 1,386.50 | 83.61 |
| Sep 2024 | 8,038.20 | 1,335.80 | 80.45 |
| Dec 2024 | 8,381.20 | 1,400.00 | 16.97 |
| Year | Revenue (Cr) | Net Profit (Cr) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2020 | 17,517.00 | 1,969.90 | 122.22 | 938.56 | 12.98 | 0.11 |
| 2021 | 19,047.50 | 1,903.60 | 117.67 | 1,060.20 | 11.06 | 0.15 |
| 2022 | 21,545.20 | 2,112.20 | 131.57 | 1,154.59 | 11.35 | 0.16 |
| 2023 | 24,669.70 | 4,470.30 | 271.47 | 1,397.73 | 19.35 | 0.05 |
| 2024 | 28,011.10 | 5,563.20 | 335.22 | 1,693.93 | 19.74 | 0.06 |
The following table shows the income statement of Dr Reddys Laboratories.
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
|---|---|---|---|---|---|
| Sales | 28,011 | 24,669 | 21,545 | 19,047 | 17,517 |
| Other Income | 894 | 1,055 | 484 | 291 | 620 |
| Total Income | 28,905 | 25,725 | 22,029 | 19,338 | 18,137 |
| Total Expenditure | 21,548 | 19,570 | 18,942 | 16,406 | 16,209 |
| EBIT | 7,357 | 6,154 | 3,086 | 2,932 | 1,927 |
| Interest | 171 | 142 | 95 | 97 | 98 |
| Tax | 1,623 | 1,541 | 878 | 931 | -140 |
| Net Profit | 5,563 | 4,470 | 2,112 | 1,903 | 1,969 |
The following table summarizes key elements from the balance sheet.
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
|---|---|---|---|---|---|
| Share Capital | 83 | 83 | 83 | 83 | 83 |
| Reserves & Surplus | 28,171 | 23,202 | 19,129 | 17,558 | 15,515 |
| Current Liabilities | 9,588 | 8,572 | 9,765 | 8,103 | 7,214 |
| Other Liabilities | 1,021 | 426 | 768 | 871 | 412 |
| Total Liabilities | 38,863 | 32,285 | 29,746 | 26,616 | 23,225 |
| Fixed Assets | 11,294 | 9,701 | 8,867 | 9,210 | 7,894 |
| Current Assets | 24,805 | 20,425 | 17,782 | 14,550 | 12,599 |
| Other Assets | 2,763 | 2,157 | 3,097 | 2,855 | 2,732 |
| Total Assets | 38,863 | 32,285 | 29,746 | 26,616 | 23,225 |
The table below presents some of the key financial ratios for Dr Reddys Laboratories.
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 335.22 | 271.47 | 131.57 | 117.67 | 122.22 |
| Diluted Eps (Rs.) | 334.59 | 270.90 | 131.21 | 117.34 | 121.99 |
| Book Value /Share (Rs.) | 1,693.93 | 1,397.73 | 1,154.59 | 1,060.20 | 938.56 |
| Dividend/Share (Rs.) | 40.00 | 40.00 | 30.00 | 25.00 | 25.00 |
| Face Value | 5 | 5 | 5 | 5 | 5 |
| Gross Profit Margin (%) | 31.51 | 30.01 | 19.73 | 21.84 | 17.64 |
| Operating Margin (%) | 26.26 | 24.94 | 14.32 | 15.39 | 11.00 |
| Net Profit Margin (%) | 19.86 | 18.12 | 9.80 | 9.99 | 11.24 |
| Return on Equity (%) | 19.74 | 19.35 | 11.35 | 11.06 | 12.98 |
| ROCE (%) | 25.13 | 25.95 | 15.44 | 15.84 | 12.04 |
| Return On Assets (%) | 14.35 | 13.96 | 7.33 | 7.33 | 8.72 |
| Current Ratio (X) | 2.59 | 2.38 | 1.82 | 1.80 | 1.75 |
| Quick Ratio (X) | 1.92 | 1.82 | 1.30 | 1.24 | 1.26 |
| Debt to Equity (x) | 0.06 | 0.05 | 0.16 | 0.15 | 0.11 |
| Interest Coverage Ratios (X) | 51.59 | 51.85 | 44.39 | 42.90 | 19.61 |
| Asset Turnover Ratio (%) | 0.79 | 0.80 | 0.56 | 0.60 | 75.42 |
| Inventory Turnover Ratio (X) | 0.80 | 0.85 | 0.86 | 1.03 | 5.00 |
| 3 Yr CAGR Sales (%) | 21.27 | 18.67 | 18.10 | 15.49 | 11.08 |
| 3 Yr CAGR Net Profit (%) | 70.95 | 50.64 | 5.26 | 44.44 | 25.18 |
| P/E (x) | 3.67 | 3.41 | 6.53 | 7.68 | 5.11 |
| P/B (x) | 3.63 | 3.31 | 3.73 | 4.26 | 3.32 |
| EV/EBITDA (x) | 11.62 | 10.32 | 17.01 | 18.20 | 17.27 |
| P/S (x) | 3.67 | 3.12 | 3.33 | 3.94 | 2.96 |
With the stock currently trading at Rs 1160.00, Dr Reddys Laboratories' performance and high-volume activity are being closely monitored by investors.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
